ARKG vs RYLD
ARK Genomic Revolution ETF vs Global X Russell 2000 Covered Call ETF
- • RYLD has the lower expense ratio at 0.60% vs 0.75% for ARKG.
- • RYLD pays a higher dividend yield (6.81%).
Side-by-side metrics
| Metric | ARKG | RYLD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.60% |
Dividend yield Trailing 12-month yield. | 0.00% | 6.81% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $1.36B |
YTD return | 44.53% | 10.76% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.54 |
P/E ratio | — | 18.65 |
Last price | $43.17 | $16.05 |
Inception | — | — |
Issuer | ARK | Global X |
ARKG top holdings
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
RYLD top holdings
| RSSL | Global X Russell 2000 ETF | 102.91% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About RYLD
RYLD (Global X Russell 2000 Covered Call ETF) is Russell 2000 covered call strategy for income. Managed by Global X, the fund carries $1.4B in assets under management, an expense ratio of 0.60%, a dividend yield of 6.81%. Its largest holding is Global X Russell 2000 ETF (RSSL), which represents 102.9% of the portfolio. Real Estate is the fund's largest sector exposure at 6.8%.